GORE ANNOUNCES FIRST PATIENT ENROLLMENT IN THE GORE® EXCLUDER® IBE PLUS STENT GRAFT PIVOTAL STUDY

Trial StartGORE® EXCLUDER® IBE PLUS STENT GRAFTPositive

AI Analysis

Summary

W. L. Gore & Associates announced the first patient enrollment in the IBE Plus Pivotal Study, a clinical trial evaluating the GORE® EXCLUDER® IBE PLUS STENT GRAFT investigational device.

Clinical Trial Data

Patients

Outcome Details

First patient enrolled in IBE Plus Pivotal Study

Importance:3/10

Sentiment:

0.30

clinical trialmedical deviceinvestigationalpivotal study

Related Companies

$MDCE $UTHR $TRAX

Read the original article

Published by PR Newswire Pharma on October 1, 2026 10:29 AM

Read Original